These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12973000)

  • 41. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission.
    Corapcioglu F; Oncel S; Berberoğlu K; Klç SC; Aydoğan A; Doğan S
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):74-5. PubMed ID: 19125095
    [No Abstract]   [Full Text] [Related]  

  • 42.
    Mestres-Marti J; Llinares-Tello E; Sabaté-Llobera A; Gràcia-Sánchez L; Robles-Barba J; Gámez-Cenzano C
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):183-185. PubMed ID: 30389619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
    Kostakoglu L; Coleman M; Leonard JP; Kuji I; Zoe H; Goldsmith SJ
    J Nucl Med; 2002 Aug; 43(8):1018-27. PubMed ID: 12163626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
    Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM
    Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
    [No Abstract]   [Full Text] [Related]  

  • 46. Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma.
    Gundlapalli S; Ojha B; Mountz JM
    Clin Nucl Med; 2002 Feb; 27(2):140-1. PubMed ID: 11786751
    [No Abstract]   [Full Text] [Related]  

  • 47. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R; Xiu Y; Zhuang HM; Alavi A
    Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.
    Montravers F; McNamara D; Landman-Parker J; Grahek D; Kerrou K; Younsi N; Wioland M; Leverger G; Talbot JN
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1155-65. PubMed ID: 12192560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 18F-FDG PET/CT Imaging of Hodgkin Lymphoma in a Child with Common Variable Immunodeficiency.
    Tatci E; Biner IU; Tanyildiz HG; Ozmen O; Gokcek A; Sahin G; Tazeler Z
    J Nucl Med Technol; 2016 Dec; 44(4):259-260. PubMed ID: 27363447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
    [No Abstract]   [Full Text] [Related]  

  • 51. Primary cardiac lymphoma: echocardiography and F-18-fluorodeoxyglucose positron emission tomography in selection of a biopsy site.
    Okayama S; Dote Y; Takeda Y; Uemura S; Fujimoto S; Saito Y
    Echocardiography; 2013 Jan; 30(1):E13-5. PubMed ID: 23095093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.
    Cremerius U; Fabry U; Neuerburg J; Zimny M; Bares R; Osieka R; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):23-30. PubMed ID: 11373935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?
    Brepoels L; Stroobants S
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):855-69. PubMed ID: 17908624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
    Thill R; Neuerburg J; Fabry U; Cremerius U; Wagenknecht G; Hellwig D; Osieka R; Günther R; Büll U
    Nuklearmedizin; 1997 Oct; 36(7):234-9. PubMed ID: 9441282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. F-18 FDG PET/CT images of a rare primer cardiac tumour: Primary Pericardial Mesothelioma.
    Ak Sivrikoz İ; Önner H; Kasapoğlu Dündar E; Çavuşoğlu Y; Dernek S
    Anatol J Cardiol; 2016 Aug; 16(8):635-6. PubMed ID: 27515105
    [No Abstract]   [Full Text] [Related]  

  • 56. Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT.
    Jain AS; Simon S; Muthukrishnan I; Gambhir A; Patil S
    Clin Nucl Med; 2017 Apr; 42(4):315-318. PubMed ID: 28195904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eighty-nine-year-old woman with fatigue and reduced appetite.
    Thayaparan AS; Haikerwal D
    Heart; 2019 Jun; 105(11):880-892. PubMed ID: 31092679
    [No Abstract]   [Full Text] [Related]  

  • 58. Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma.
    Harada S; Shinohara T; Naruse K; Machida H
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27793796
    [No Abstract]   [Full Text] [Related]  

  • 59. Positron emission tomography in the management of lymphomas: a summary.
    O'Doherty MJ; Hoskin PJ
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S128-30. PubMed ID: 12692689
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of cardiac myxoma by F-18 FDG PET.
    Agostini D; Babatasi G; Galateau F; Grollier G; Potier JC; Bouvard G
    Clin Nucl Med; 1999 Mar; 24(3):159-60. PubMed ID: 10069723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.